Guardant Health (GH) PT Raised to $70 at Barclays
Tweet
Share
E-mailGet Alerts GH Hot Sheet
Price: $164.22 -3.79%
Rating Summary:
28 Buy, 1 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 6 | New: 57
Rating Summary:
28 Buy, 1 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 6 | New: 57
Join SI Premium – FREE
Barclays analyst Luke Sergott raised the price target on Guardant Health (NASDAQ: GH) to $70.00 (from $60.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Court awards TwinStrand $245.2M in Guardant Health patent case
- SL Green Realty (SLG) PT Raised to $57 at Truist Securities
- CoreWeave (CRWV) PT Raised to $165 at Truist Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
